Enveric Biosciences (ENVB) Change in Taxes (2014 - 2015)
Enveric Biosciences (ENVB) posted Change in Taxes of $43425.0 for Q2 2015, down 72.56% sequentially from $158235.0 in Q2 2014, and down 72.56% YoY from $158235.0 in Q2 2014.
Enveric Biosciences (ENVB) Change in Taxes (2014 - 2015) Analysis & Trends
Enveric Biosciences has reported Change in Taxes for 2 years, with the latest figure at $43425.0 in Q2 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 43,425.00 |
| Jun 30, 2015 | 43,425.00 |
| Jun 30, 2014 | 158,235.00 |
| Jun 30, 2014 | 158,235.00 |